Physician profile
Daniel Pearson
NPI 1003966003
$2,074.02
in general payments reported to CMS, 2019-2025
35 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $139 · 2021: $298 · 2022: $261 · 2023: $272 · 2024: $425 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.40 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $256.12 | 2024 | |
| Novo Nordisk INC | $207.41 | 2019-2023 | |
| Lilly USA, LLC | $100.92 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $100.74 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.14 | 2022-2024 | |
| Amgen INC. | $90.63 | 2019-2020 | |
| Abbott Laboratories | $87.40 | 2024-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $69.92 | 2021-2025 | Breztri, Airsupra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.29 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $64.33 | 2021-2024 | Invega Sustenna, Xarelto |
| Sumitomo Pharma America, INC. | $51.06 | 2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.80 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.85 | 2019-2024 | Xifaxan |
| Verona Pharma, INC. | $36.44 | 2025 | Ohtuvayre |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $31.80 | 2019-2020 | |
| Grifols USA, LLC | $20.23 | 2023 | Prolastin-C Liquid |
| Sanofi-Aventis U.S. LLC | $18.02 | 2022 | |
| Amarin Pharma, INC. | $16.83 | 2019 | |
| Exact Sciences Corporation | $15.84 | 2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.23 | 2022 | |
| Ardelyx, INC. | $14.55 | 2025 | Ibsrela |
| Teva Pharmaceuticals USA, INC. | $14.51 | 2023 | Austedo |
| Adlon Therapeutics L.P. | $14.46 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.35 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.34 | 2021 | |
| Boston Scientific Corporation | $14.21 | 2021 | |
| Genentech USA, INC. | $13.70 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.64 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.50 | 2023 | Opsumit, Uptravi |
| Phathom Pharmaceuticals, INC. | $12.85 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $12.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.45 | 2021 | |
| Celgene Corporation | $12.33 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.